Add-on Acquisition • Life Science

Juniper Pharmaceuticals Acquires Molecular Profiles

On September 12, 2013, Juniper Pharmaceuticals acquired life science company Molecular Profiles for 25M USD

Acquisition Context

This is Juniper Pharmaceuticals’ 1st transaction in the Life Science sector.
This is Juniper Pharmaceuticals’ largest (disclosed) transaction.
This is Juniper Pharmaceuticals’ 1st transaction in the United Kingdom.

Explore All 3109 Add-on Acquisition Life Science Deals - Search the Database Free

M&A Deal Summary
Date	September 12, 2013
Target	Molecular Profiles
Sector	Life Science
Buyer(s)	Juniper Pharmaceuticals
Deal Type	Add-on Acquisition
Deal Value	25M USD

Target Company

Molecular Profiles

Nottingham, United Kingdom

Molecular Profiles provides pharmaceutical development, clinical trial manufacturing, advanced analysis and consulting services for the pharmaceutical industry worldwide.

Explore More Deals

Browse All 215,130 Deals

FILTER BY

Buyer Type (PE or Strategic)
Deal Size ($10M to $10B+)
Sector (60 Sectors)
Deal Type
Geography
& More

Search Free

Buyer Overview 1

Buyer

Juniper Pharmaceuticals

Boston, Massachusetts, United States

Category	Company
Founded	1986
Sector	Life Science
Employees	105
Revenue	50M USD (2017)

DESCRIPTION

Juniper Pharmaceuticals, Inc. is a specialty pharmaceutical company focused on developing therapeutics that address unmet medical needs in women’s health. Juniper Pharmaceuticals was founded in 1986 and is based in Boston, Massachusetts.

Deal Context for Buyer	#
Overall	1 of 1
Sector: Life Science	1 of 1
Type: Add-on Acquisition	1 of 1
Country: United Kingdom	1 of 1
Year: 2013	1 of 1
Size (of disclosed)	1 of 1

Explore Related M&A Activity

Life Science M&A - Add-on Acquisition M&A Deals - United Kingdom M&A - 2013 M&A